NRX PHARMACEUTICALS INC (NRXPW)
Institutional ownership reported to the SEC as of Q1 2026, across 20 quarters.
1
Reporting holders
$347
Reported value
0.0%
Held as options
-2
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| WOLVERINE ASSET MANAGEMENT LLC | $347 | 23,593 | 0.00% | 11q | +5.8% |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 1 | $347 | 23,593 | 0 | 1 | 0 | 0.0% |
| Q4 2025 | 3 | $2.4K | 35,557 | 0 | 2 | 1 | 0.0% |
| Q3 2025 | 4 | $4.5M | 3,063,963 | 2 | 0 | 1 | 0.0% |
| Q2 2025 | 3 | $5.3K | 62,243 | 0 | 2 | 0 | 0.0% |
| Q1 2025 | 4 | $5.2K | 74,242 | 0 | 1 | 2 | 0.0% |
| Q4 2024 | 4 | $6.2K | 48,081 | 0 | 0 | 2 | 0.0% |
| Q3 2024 | 7 | $3.9K | 87,433 | 2 | 1 | 1 | 0.0% |
| Q2 2024 | 5 | $4.7K | 77,448 | 2 | 2 | 0 | 0.0% |
| Q1 2024 | 4 | $2.8K | 15,677 | 2 | 0 | 1 | 0.0% |
| Q4 2023 | 3 | $3.0K | 23,081 | 0 | 0 | 2 | 0.0% |
| Q3 2023 | 5 | $3.0K | 37,982 | 3 | 0 | 0 | 0.0% |
| Q2 2023 | 2 | $4.3K | 17,144 | 1 | 0 | 0 | 0.0% |
| Q1 2023 | 2 | $3.7K | 20,485 | 1 | 0 | 0 | 0.0% |
| Q4 2022 | 1 | $4.3K | 17,129 | 0 | 0 | 0 | 0.0% |
| Q3 2022 | 1 | $5.0K | 17,129 | 0 | 0 | 0 | 0.0% |
| Q2 2022 | 2 | $4.0K | 32,807 | 1 | 0 | 0 | 0.0% |
| Q1 2022 | 2 | $24.0K | 27,129 | 0 | 0 | 2 | 0.0% |
| Q4 2021 | 3 | $110.0K | 59,856 | 0 | 2 | 1 | 0.0% |
| Q3 2021 | 4 | $486.0K | 102,647 | 2 | 0 | 2 | 0.0% |
| Q2 2021 | 3 | $573.0K | 160,817 | 3 | 0 | 0 | 0.0% |